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Tenascin (TN), a large extracellular matrix glycopro-
tein, is transiently expressed during etnbryonic de-
veloptnent, but is absent from most normal adult 
tissues. TN is reexpressed, however, in healing 
wounds, in the stroma of some tumors, and in fibrotic 
diseases such as systemic sclerosis (SSc) and rheuma-
toid arthritis. To clarify the mechanisms regulating 
TN expression, we studied the eff~cts of selected 
cytokines (PDGF, bFGF, TGF-{3, IL-l, IL-4, IL-6, 
IFN-y, and TNF-a) found in fibrotic tissue on TN 
expression by dermal fibroblasts. lL-4 strongly in-
duced TN protein levels (up to 10-fold over the basal 
level), whereas PDGF and bFGF were less potent 
inducers of TN than IL-4. All other cytokines tested, 
including TGF-{3, did not stimulate TN synthesis. 
Systemic scle rosis (SSc), an auto immune di sorde r, is cha racte ri zed by the excess ive d epositio n o f extracellu-la r matrix componen ts in the skin and inte rna.1 o.rgans (Fa gundus and LeRoy, 1994). Tenascin is an extracel-lul a r m atrix g lycoprotein th at m ay play a ro le in the 
pa thogen es is of scle roderma. It is a la rge di sulfide-linked h exameric 
g lycopro te in w ith a subunit m o lecular mass ranging fro m 220 to 
320 kDa (Eri c kson and B o urdo n, 1989). In adult t issues, tenascin is 
p resen t as a thin band in thc papiHary de rmis (Ligh tn e r et nl, 1989) 
and is absen t fro m m os t other ti ssues. Tenasein is t ransien t ly 
reexpressed in wound healjng at the stages prcccding collagcn 
dep os itio n and cell mig ratio n (Whitby and Ferg u son , 1991 ; Gailit 
and C lark, 1994) . Tcn asc in reappears in some p athologic condi-
tio n s, including can cer (Koukoulis et ai, 199 1) and fibro ti c and 
immun ologic di seases su ch as SSe and rheumatoid arthriti s (Lacour 
el ai, 1992; Sa lte r , 1993) . 
Altho u gh immuno histoch emistry has sh o wn that tenascin is 
inc reased in th e d ermis of patients with scle ro de rma (LaCour et ai , 
1992) , thc pro duction o ften ascin b y dermal fi bro bl as ts h as not b een 
de m o nstra ted . W e the re fo re investiga ted the regulatio n of tenascin 
by cytokincs be lie ved to be involved in fibrosis , usin g culture d 
de rma.! fibro blas ts obta ine d fro m h ea.lthy subj ects and £i'om patients 
with scle ro derm a. W e tes ted the effects o f pla te le t- de rived g row th 
[,lc to r (PDG F) , basic fib ro blas t g ro w th fa c to r (bFG F) , tran sformin g 
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IL-4 also increased TN mRNA expression, and this 
effect was blocked by actinomycin D. Cycloheximide 
increased basal TN mRNA expression and induced 
TN mRNA in IL-4-treated fibroblasts, suggesting 
that repressor protein(s) may regulate transcription 
of the TN gene. Although no differences in constitu-
tive TN expression or effects of cytokines on TN 
expression were observed between SSc and healthy 
fibroblasts, these data are consistent with the obser-
vations that high levels of both IL-4 and, TN are 
present in the affected skin of patients with SSc. 
These results suggest that the high level of TN found 
in the affected tissue of patients with SSc results from 
the high level ofIL-4 present. Key words: PDGFlbFGFI 
TGF{3. ] l,west Del'lltatol107:856-859, 1996 
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growth fa c tor-/3 (TGF-/3), inte rl e ukin (1L)- l , lL-4, IL-6, interfer-
on-/, (IFN-/,), ~lI1d tumor necro sis fa ctor-a (TNF-a ) on temlscin 
expressio n at both the prote in and mRNA le vels . Our data indicate 
that I L-4 is a po te nt inducer o f tenascin , where as PDG F and bFG F 
arc mode rate inducers. 
MATER.J ALS AND METH O DS 
CeU Cultures Fibroblasts were obta ined by skin biopsy from the affec ted 
areas (dorsa l fo rearm) of patients with diffuse cutan cOllS SSc with less than 
2 y of skin thickening. Contro l fibroblasts were obtained by skin biopsy of 
hea lthy donors (within sever,,1 days o f SSc biopsy) ; these were matched wi th 
each SSc patient fo r age, race, gender, and biopsy site and were processed 
in para ll el. Newborn foreskin fib roblasts were obtained from the delivery 
suites o f afElia tcd hospitals. Pril11a ry explan t cul tures were es tablished and 
propagated as described prcviously (Yamakagc Ci nl, '1992). Fibroblasts 
between the third and fi fth subpassagcs were used for experiments. 
Cytoldnes and Chemicals IL-4, IL-l . IFN-"y, actinomycin 0 , and 
cycloheximide were purchased fro m Sigma (St. Lo ui s. M O); T NF-a was 
obtained fro l11 Promega (Madison, WI); bFGF. PDGF, and TGF-J3 were 
obtained fro m U pstate Biotechnology (Lake Placid, NY) ; and IL-6 was 
purchascd ITom Pepro T ech (Rocky Hill, NJ) . 
RNA Preparation and Northern Blot Analysis Fibroblasts were 
grown to confluen ce ill DuJbecco's 111 0d ifi cd Eagle's lTI cdiuI11 sllppic I11CIltcd 
with 10'y" fetal bovine serum, and then incuba ted for 48 h in serum-free 
medium (Dulbecco's modified Eagle's medium pIllS 0.1 % bovine serum 
albumin) . T he cells were stimulated with v"rious cytokines-IL- l , IL-4. 
IL-6. TNF-a, or IFN-"y-for 3, 6, or 24 h. T otal RNA w"s extracted and 
anal yzed by Northcrn blot as described previously (Y"makage el ai, 1992). 
Tenascin eDNA probc was kindly provided by Dr. Mario Bourdon (La Jolla 
Institu te for Experimental Medicinc, La JolI:I, C Al . T he fi lters were scanned 
wi th a phosphorimagc r scanner (Molecular Dynamics. Sunnyvale. CAl. 
Fil te rs were stripped by boiljng for 30 min in 0.1 % sodium dodccyl sulfate 
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Figure 1. Effects of cytokines on tenasci.n (TN) mRNA levels in 
healthy fibroblasts. Cells were stimulated with the indicated cytokines for 
3 h (lanes 4,7,1 0,13,16),6 h (Inl/es 5,8,1 1,14, 17), and 24 h (In/Irs 6,9,12, 15, 18) . 
Control cells received only serum-free medium for 3 h (lmle 1). 6 h (I"I/e 2), and 
24 h (lmle 3). Membranes were hybridized with tenascin cDNA probe (A) and 
rehybridized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
prob e (B). 
and 0.1 X sodium citrate/chlOlide bufFer and rehybridized with glyceralde-
hyd e-3-phosphate dehydrogenase probe. 
ItnJ:I1unoblottiug Cell s at 10' were plated in 1 ml of 10% fetal bovine 
seruITl i1112-well plates, allowed to adhere for 6- 8 h, and d,en incubated in 
serurn-fi-ee medium (1 ml) for 24 h. T he indicated cytokines were added in 
serUln-free mcdium. After 3 d of incubation, the medium was collected. 
Ren~ai.n.illg cells and deposited extracellular mau'ix (denoted as cell / matrix 
layer) were lysed in lysis buff'er (5 111M Tris-CI, pH 8.0, 150 mM NaC!, 
0.02°/., sodium azide [NaN,,], 0.1 'x, sodium dodecyl su lfate, 1 J.Lg aprotinin 
per m l , 1% N onidct P-40, 0.5'V" sodium dcoxycholate , I mM sodium 
orthovanadate, and 100 J.Lg phenylmethylsulfonyl fluoride per ml). Aliquots 
of conditioned medium (35 J.Ll; 3.5% of the medium from one well) or 
cell /matrix layers (20 /-Lg; abou t 20'Yo of the cell / matrix layer in one well) 
(protein content measured by BCA Pierce assay; Rockford, IL) were 
separated on 5% sodium dodecyl sulf:,te-polyacrylamide gels and trans-
ferred to nitrocellulose membranes. T he membranes were stained with 
amido black before blockin g to control for equal loading. T he membranes 
were blocked with 1% bovine serum albumin and incubated overnight with 
an anti-human tenascin monoclonal an tibody (NEClb) (kindly provided by 
Dr. 'Wolfgang R ettig. Thomae Biberach, Germany) (Rettig and Garin-
Chesa, 1989). The membranes were washed in Tris-buff'ered salin e/Tween, 
incubated with anti-mouse antibody conjugated to horseradish peroxidase, 
and vvashed again. T he tenascin bands were detected using the Enhanced 
Chemiluminescence Detection System (A.1llersham, Arlington Heights. IL) . 
RESULTS 
IL-4 Upregulates Tenascin mRNA Levels in Dermal Fibro-
blast:s To investiga te the regulation of tenascin in dennal fibro-
blasts, we studied the e ffects oflL-1, IL-4, IL- 6 , TNF-a, and IFN- y 
on tenascin mRNA levels in SSc and in h ealthy skin fibroblasts a t 
concentrations ranging from 0 .1 to 100 ng p er ml. Based on these 
preliminary experiments, the following concentrations (which are 
the nU.l1inlal concentrations providing m aximal stimulation) were 
used in subsequent experiments: fL-l, 10 ng per 111.1; IL- 4, 2 ng per 
ml; IL-6, 10 n g p er ml ; TNF-a, 10 n g per 111.1 ; and IFN-y, 100 U p er 
m 1. Total RNA was extracted fi'om c ultured fibroblasts after 3, 6, 
or 24 h of stimulation and an al yzed by Northe rn blot (Fig 1). Two 
tenascin mRNA transcripts were d etected . Increases in tenascin 
mRNA levels were induced b y TL-4 at all time points, with 
maxin'lum stimulation at 24 h . No othe r cytokin es showe d stimu-
lation at 3 or 6 h, but after 24 h of treatment, IL-1 and TNF-a 
sho-wed slight stimulatory e ffects. IL-6 h ad no effect and IFN-y 
slightly decreased tenascin mRNA levels. Only IL-4 significantly 
induced tenascin mRNA expression in both SSc (fold increase: 
3.4 ± 0 .6, m ean ::t: SEM, p < 0.01, data not shown) and healthy 
fibroblasts (3 .3 ::t: 0.6, p < 0.001) (Fig 2). Co- stimulation with 
I.FN-y slightly decreased th e stimulatory efFects of lL-4 in SSc and 
healthy fibroblasts (Fig 2) . N o signifIcant differen ces were detected 
in basal levels of te n ascin mRNA b e tween healthy and SSc 
fibroblasts. T h e pattcm of responses to cytokines with regard to 
tenascin mRNA expression was similar in SSc and health y fibro-
blasts. 
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Figure 2. IL-4 increases tenascin mRNA levels in dermal f!~fo­
blasts. Tenascin/ glyceraldehyde-3-phosphate dehydrogenase ratio ('IN/ 
GAPDH) in normal (n = 4) fibrob lasts after stimulation with v~rious 
cytokines fo r 24 h. ' Statistica lly significant diff'erence in ratio, p < 0,001. 
E",ol' llnl's, mean ± SEM. 
IL-4, bFGF, and PDGF Stimulate the Production of Ten-
ascin in Dermal Fibroblasts Tenascin protein levels w~re 
m easured in condition e d m edium and ill cell/ matrix layers obt~j11ed 
from fibroblasts treated with cytokines for 72 h . Two polypeptides 
(320 and 220 kDa), corresponding to the two isofOlms of tell ascin, 
were d etected (Fig 3). T h e larger isoform was de tected in b9* ~he 
ceIl / mao'L'X layers and in conditioned m edium, whereas the s111al1 
isoform was d etected o nly in conditioned m edium. IL-4 both 
increased the deposition of tenascin in the cell / matrL'X layer~ (Fig 
3A) and induced the secretion of tenascin into conditio ned I11l!djum 
(Fig 3B) . To quantify the increase of tenascin secretion after IL-4 
stimulation, aliquots of conditione d m edium obtaine d from lj11-
treated fibroblasts w ere run adjacent to aliquots represf!nting 
various arnounts of condition ed m edium o btain e d from IL-4 -
treated cells. T h e inten sity of the m ajor tenascin po lypep tide from 
35 ILl of WlStimulated fibroblast m edium was slightly lower thaI') the 
intensity from 3.5 ILl of stimulated fibroblast m edium, indicating 
stimulation of ten ascin secre tion of ab o ut la-fold by IL-4 (d1t ;t not 
shown) . Treatm en t of fibroblasts with IL-l, IL-6, TNF-a , IFN-y, 
or TGF-{3 did not ch ange tenascin production significantly (Fig 3). 
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Figure 3. Induction of tenascin (TN) protein synthesis ill healthy 
fibroblasts after IL-4 stimulation. Cul tured fibroblasts were stim 'llated 
with the indicated cytokines for 72 h, the medium was collected, 'Ind the 
cells and extracellular matrix were lysed in lysis buff'er, as described in 
Mnlel;"ls "lid J\llci/wds. Aliquots of cell / ma tr;'" layer (Aj or conditioneej 'lledia 
(Bj were analyzed by western blot as described in Nla lerin/., alld Met/lOrIs. 
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Figure 4. PDGF AB and bFGF induce tenascin protein synthesis in 
scleroderma fibroblasts. Cultured fibroblasts were stimulated with 
PDGF AB (20 ng per ml). bFGF (10 ng per Illl). and IL-4 (2 ng per Illl) . 
Aliquots of conditioned 111CdiLUll, 110rI11~llizl!d for ccU Ilumber, were ana-
lyzed by western blot as described ill Materials a/ld Me/hod ... 
Previous reports indicated that PDGF and bFGF induce tenascin 
synthesis in several types of cells (Sharifl et ai, 1992; Rettig e/ ai, 
1994). We tested the effects of these growth factors on tenascin 
protein synthesis in SSc and h ealthy dermal fibroblasts. As shown in 
Fig 4, both PDGF and bFGF induced tenascin synthesis, but with 
a lesser potency than IL-4. It was interesting that PDGF did not 
induce tenascin mRNA levels (data not shown) . The effects of 
bFGF on tenascin mRNA levels have not been investigated. 
IL-4 Regulates Tenascin Expression at the Transcriptional 
Level To establish whether the increase in tenascin mRNA levels 
after IL-4 treatment involves transcriptional activation, we tested 
the magnitude of IL-4 induction in the presence of actinomycin D. 
Newborn foreskin fibroblasts were used for these expel'iments . 
They were shown to produce similar amounts of tenascin as 
compared with human adult dermal fibr~blasts (Rettig et ai, 1994), 
and we have established that they respond to IL-4 with kinetics 
similar to those of adult dermal fibroblasts (data not shown). 
Foreskin fibroblasts were treated with IL-4 for 6 h in the presence 
or absence of a transcdptional inhibitor, actinomycin D (Fig 5). 
Actinomycin D completely blocked the IL-4-mediated increase in 
tenascin mRNA, suggesting that lL-4 stimulation of tenascin 
mRNA is not mediated via increased message stability, but rather 
involves direct activation of transcription of the tenascin gene 
and/or other genes involved in tenascin gene regulation. Tn addi-
tion, we asked whether this stimulation requires the synth esis of 
new proteins. Cycloheximide, an inhibitor of protein synthesis, was 
added to foreskin fibroblasts together with IL-4 for 6 h (Fig 5). 
Act. 0 
Figure 5. Actinomycin D blocks the 
transcription of tenascin (TN) gene in 
foreskin fibroblasts stimulated with 
IL-4. Foreskin fibroblasts were stimulated 
for 6 h with lL-4 (Inlle 2) . actinomycin D 
(Act. D; lalle 3), IL-4 and actinomycin D 
(lnll e 4) , cycloheximide (eyclo; /""" 5). or 
lL-4 and cycloheximide (Inllc 6). Control 
cells received serum-free medium (Cont .. 
Inlle 1). Membranes were hybridized with 
tenascin cDNA probe (A) and rehybrid-
ized with glyceraldehydc-3-phosphate de-
hydrogenase (GAPDH) probe (B). C, TN/ 
GAPDH ",tio in fibroblasts (n = 3). 
' Statistically significant difference from 
control, p < 0.05 . En'ol' hnrs, mean ::!: SEM. 
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Cyclohe;-..'imide increased basal tenascin mRN A expression and 
superinduced tenascin mRNA in lL-4-treated fibroblasts, suggest-
ing that repressor protein(s) regulate transcription of the tenascin 
gene in human fibroblasts. 
DISCUSSION 
Previous studies have identified severa l cytokines as inducers of 
tenascin expression in various tissue culture systems . For example, 
TGF-/3 increased tenascin synthesis in chick embryo fibroblasts 
(Pearson et ai, 1988; C hiquet-Ehrismann et ai, 1989); PDGF BB and 
angiotensin II induced tenascin mRNA and protein in rat smooth 
muscle cells (Sharifi et ai, 1992; La Fleur et ai, 1994); bFGF induced 
tenascin synthesis in several cell types, including Swiss 3T3 cells 
(Tucker et ai, 1993); and IL-l increased tenascin production in 
human synovial fibroblasts (McCachren and Lightner, 1992). The 
combination of [L-1, IL-4, and TNF-a induced high levels of 
tenascin synthesis in human fetal conjunctival fibroblasts (Rettig et 
ai, 1994). In tlus study, we demonstrate that only some of these 
cytokin es are capable of stimulating tenascin expression in human 
dermal fibroblasts. Among the cytokin es tested, IL-4 was the most 
potent inducer of tenascin synthesis in human fibroblasts. IL-4 
increased tenascin mR.NA levels more than 3- fo ld and tenascin 
protein levels more than 10-fold. Tenascin protein was also mod-
erately induced by PDGF and bFGF. Moreover, we have shown 
recently that all three PDGF isoforms are equally potent in stimu-
lating tenascin synthesis in newborn foreskin fibroblasts.' In con-
trast to lL-4, however, PDGF did not affect tenascin mRNA levels. 
This observation suggests that different regulatory mechanisms are 
used by these two cytoki..nes, which may be relevant to the observed 
differences in their potencies. 
Surprisingly, we found 110 significant effects of TGF-/3 on 
tenascin expression in human fibroblasts. A recent study by Rettig 
et al (1994) also demonstrated that TGF-/3 has various effects on 
tenascin expression in fibroblasts and that TGF-/3 reduced tenascin 
secretion in newborn fibroblasts. [n the same study (Rettig et ai, 
1994), tenascin secretion was analyzed in fetal cOl'Uunctival fibro-
blasts after stimulation with [L-l, IL-4, and T NF-a. In agreement 
with the data presented herein , IL-4 induced tenascin expression; 
however, those investigators found that IL-l and TNF-a also 
induced tenascUl synthesis. Moreover, the combination of IL-l , 
IL-4, and T NF-a was shown to cause a syn ergistic increase in 
tenascUl expression in conjuncti va l fibroblasts, whereas in our 
system, tlus combination increased tenascin levels only slightly in 
comparison with IL-4 alone (data not shown) . The observed 
differences are not due to variations in cytokine concentrations, 
1 Stepniakowska j , LcIloy EC, Trojanowska M; Platelet-derived growth 
f.,cto r -AA. -All , and -BB isoforms stimula te tenascin production equiva-
lently in hum,m fibroblasts. Mol Bioi Cdl 6:125 . 1995 (abstr.). 
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because in the sttldy by Rettig el ti l (1994), a dose-response curve 
for tenascin induction with TNF- c; and IL-1 reached a plateau with 
10 ng per ml and 1 ng per ml, respectively; similar cytokine 
concentrations were used in our study. Our results also differ liom 
those of a sttldy of human synovial fibroblasts i.n which IL- l 
induced tenascin protein and mRNA (McCachren and Lightner, 
1992). Together, these observations suggest that tenascin expres-
sion by fibroblasts may be regulated in a tissue-specific manner. 
In conclusion, this study demonstrates that buman dermal fibro-
blasts display a novel pattern of responses to cytokines with rega rd 
to tenascin synthes is. Most signjficantly, two of the cytokines, IL-4 
and PDGF, w hjch stimulate the synthesis of ten3scin ill "itm, have 
been found to be elevated in the skin of patients with SSc 
(Yatnakage e/ ai , 1992)2 and therefore may be directly responsible 
for the tenasc in production in SSc lesions. In conjunction Witll our 
ob servation of similar le vels of tenascin expression by passaged 
control and SSc dermal fibroblasts in the absence or presence of 
IL-4, these findings sugges t that control and SSc fibroblasts may not 
be intrinsically difFerent in their responses to TL-4 . Rather, the h.igh 
leve l of IL-4 in SSc, secreted by mast cells, which are present in 
high numbers and are activated in SSc lesions (Claman , 1989; 
Gruber, 1995), may lead to a hi.gh level of tenascin express ion. In 
addition, 11-4 is present at elevated levels in SSc serum (Needleman 
et aZ, 1992). Further studies are needed co determine the e ffects of 
tenascin on the cells present in fIbrotic lesions and to understand the 
roles of IL-4 and tenascin in the pathogenesis of SSc. 
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